|
HDAC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.918400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.978600E-04 |
| Normal-vs-Stage2 |
3.804000E-02 |
| Normal-vs-Stage3 |
9.488200E-01 |
| Normal-vs-Stage4 |
9.730800E-01 |
| Stage1-vs-Stage2 |
8.822200E-01 |
| Stage1-vs-Stage3 |
1.066000E-01 |
| Stage1-vs-Stage4 |
1.471600E-01 |
| Stage2-vs-Stage3 |
2.008400E-01 |
| Stage2-vs-Stage4 |
2.567200E-01 |
| Stage3-vs-Stage4 |
9.909600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.596200E-03 |
| Normal-vs-AfricanAmerican |
1.252840E-01 |
| Normal-vs-Asian |
3.976300E-02 |
| Caucasian-vs-AfricanAmerican |
4.453000E-01 |
| Caucasian-vs-Asian |
6.339400E-01 |
| AfricanAmerican-vs-Asian |
4.290000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.769680E-04 |
| Normal-vs-Female |
7.105200E-01 |
| Male-vs-Female |
3.434700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.312850E-01 |
| Normal-vs-Extreme_Weight |
5.67099999999598E-05 |
| Normal-vs-Obese |
2.567400E-01 |
| Normal-vs-Extreme_Obese |
2.523700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.200830E-01 |
| Normal_Weight-vs-Obese |
6.073600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.971600E-01 |
| Extreme_Weight-vs-Obese |
1.028370E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.572000E-01 |
| Obese-vs-Extreme_Obese |
2.943800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.904600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.925700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.232900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.386030E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.752500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.568350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.497600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.059900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.183800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.112200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.900700E-03 |
| Normal-VS-Type2 PRCC |
2.612900E-04 |
| Normal-VS-KIRP CIMP |
6.260200E-02 |
| Normal-VS-Unclassified PRCC |
1.743710E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.783700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.572170E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.932600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.10790000000549E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.234800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.553600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67490000000581E-05 |
| Normal-vs-N1 |
8.377900E-02 |
| Normal-vs-N2 |
4.004500E-02 |
| N0-vs-N1 |
4.026600E-04 |
| N0-vs-N2 |
9.620400E-01 |
| N1-vs-N2 |
1.094970E-01 |
|
|
